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Antibodies to Nipah 
or Nipah-like 
Viruses in Bats, 
China 
To the Editor:  Hendra  virus 
(HeV) and Nipah virus (NiV), the only 
known members of the genus Henipa-
virus, are 2 emerging paramyxovirus-
es that are highly pathogenic in a va-
riety of vertebrate animals, including 
humans (1). Since the initial discovery 
of the viruses in Australia and Ma-
laysia (2,3), sporadic HeV outbreaks 
have been reported from 1995 to 2007 
in Australia (4), and regular NiV out-
breaks have occurred in Bangladesh 
(5) and India (6). Numerous frugivo-
rous bat species (genus Pteropus), 
and some insectivous bat species have 
been found to be reservoir hosts of 
henipaviruses in Australia and Asian 
countries (7–9).
In this study conducted during 
2004–2007, bats were trapped within 
their natural habitat from 10 provinces 
in mainland People’s Republic of Chi-
na. Serum, pharyngeal, and fecal swab 
samples were collected and stored as 
described previously (10). An ELISA 
was developed to detect antibodies 
to the NiV nucleocapsid (N) and at-
tachment glycoprotein (G) proteins. 
For conﬁ  rmation,  ELISA-positive 
samples were tested by using West-
ern blot against a recombinant NiV G 
fragment (aa 71–193) fused with the 
maltose-binding protein. Virus neu-
tralization tests were conducted with 
live NiV and HeV under Biosaftey 
Level 4 containment in Australia. In 
addition, a surrogate neutralization 
test was developed by using recom-
binant env– HIV-1, pseudotyped with 
NiV G and F. RNA was extracted by 
using the QIA amp Viral RNA Mini 
Kit (QIAGEN, Hilden, Germany). 
Reverse transcription–PCR (RT-PCR) 
was performed by using primers 
against the NiV N gene as described 
previously (3).
In total, 692 bat serum specimens 
were screened for antibody to NiV N 
or G protein (or both) by ELISA, and 
33 were positive (online Appendix Ta-
ble, available from www.cdc.gov/EID/
content/14/12/1974-appT.htm). These 
specimens were from 9 of the 23 bat 
species examined in this study. Of the 
33 serum samples reactive in ELISA, 
25 with sufﬁ  cient quantity left were 
further tested by Western blot, and 
17 of 25 serum samples were reactive 
with MBP-NiV G fusion fragment, 
but not with the control MBP. None 
of the samples inhibited entry of NiV 
F/G-pseudotyped virus or neutralized 
either HeV or NiV. No NiV-speciﬁ  c 
RNA was detected by RT-PCR among 
479 fecal swab samples and 67 throat 
swab samples tested; therefore, virus 
isolation was not attempted.
This study systematically inves-
tigated NiV presence among bats in 
China. The detection of henipavirus 
antibody suggests that several bat spe-
cies have been exposed to NiV or a 
closely related virus. The prevalence 
of antibody was especially prominent 
among  Myotis species from Yunnan 
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Province. Antibody was detected in 
samples from 3 of 4 Myotis species 
captured in the same location in 2006 
and 2007. A relatively high prevalence 
of henipavirus antibody was also 
found among Rousettus leschenaul-
tia samples from Hainan Province in 
2007. Notably, Yunnan and Hainan 
are both located in southern China. 
Although pteropid bats are not found 
in China, these data suggest henipavi-
ruses could be introduced into China 
by other susceptible bat species that 
overlap their habitat with pteropid bats 
in neighboring countries.
Several possibilities may ex-
plain the failure to detect neutral-
izing antibodies. One might be the 
unique immune response among those 
nonpteropid bats, which results in a 
low level of neutralizing antibodies 
that are difﬁ  cult to detect in the cur-
rent assay systems. Alternatively, and 
perhaps more likely, >1 Nipah-like vi-
ruses could be circulating among the 
bat populations sampled in this study, 
producing antibodies that cross-react 
with, but do not neutralize, the proto-
type Malaysian NiV virus isolate. This 
phenomenon has been observed previ-
ously by our group for severe acute 
respiratory syndrome (SARS)–like 
viruses in horseshoe bats, whose sera 
cross-reacted with, but did not neutral-
ize, the SARS virus in humans (10).
Obtaining serologic evidence of 
viruses in bat populations is typically 
more successful as a screening tool 
than either nucleic acid based assays 
or virus isolation; this is likely attrib-
utable to the often low-level of virus 
replication, the transient nature of the 
infection in bats, or both. The inability 
to amplify NiV sequences may have 
been attributable to the viral RNA pres-
ent among these samples being below 
the threshold of detection in our assay 
or to the absence of infection in the 
population at the time of sampling. In 
addition, the primers used in the PCR 
may target regions of the NiV N pro-
tein that exhibit substantial sequence 
divergence in a Nipah-like virus.
Bat species in the genera Rouset-
tus, Myotis, Miniopterus, and Hippo-
sideros naturally reside in trees, build-
ings, and caves that can be in close 
proximity to human residential areas, 
which increases the potential of trans-
mission of zoonotic pathogens from 
bats to humans. The increased risk 
for these zoonotic infections to spread 
from bats to humans in areas of co-
habitation is best illustrated by the re-
peated spillover events involving NiV 
in Bangladesh (5). Given the present 
initial evidence of exposure among 
bats in mainland China shown here, 
there is an urgent need to continue and 
expand surveillance studies for heni-
paviruses in China and elsewhere on 
the Asian continent.
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Erratum—Vol. 14, No. 9
The article Obligations to Report Outbreaks of Food-
borne Disease under the International Health Regulations 
(2005) (M.D. Kirk et al.) contained incorrect ﬁ  gures in the ab-
stract and conclusion. The text stated that 7 (50%) of 14 out-
breaks would have required notiﬁ  cation to the World Health 
Organization (WHO). The correct proportion is 6 (43%) of 14 
outbreaks that would have required notiﬁ  cation to the WHO. 
The article has been corrected online (www.cdc.gov/eid/
content/14/9/1440.htm).LETTERS
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